Technical Analysis for KYMR - Kymera Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bearish Centerline Cross | Bearish | 3.51% | |
MACD Bearish Signal Line Cross | Bearish | 3.51% | |
20 DMA Resistance | Bearish | 0.65% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.65% | |
Inside Day | Range Contraction | 0.65% | |
Gapped Up | Strength | 0.65% | |
Bearish Engulfing | Bearish | 3.09% | |
Fell Below 20 DMA | Bearish | 3.09% | |
Fell Below 50 DMA | Bearish | 3.09% | |
Expansion Pivot Sell Setup | Bearish Swing Setup | 3.09% |
Alert | Time |
---|---|
60 Minute Opening Range Breakout | 10 minutes ago |
Up 3% | 27 minutes ago |
Rose Above Previous Day's High | 40 minutes ago |
Up 2% | 40 minutes ago |
Up 1% | about 1 hour ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/18/2024
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; and STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases. The company was founded in 2015 and is headquartered in Watertown, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Immunology Solid Tumors Immune System Autoimmune Disease Autoimmunity Rheumatoid Arthritis Hematologic Malignancies Atopic Dermatitis Dermatitis Hidradenitis Suppurativa
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Immunology Solid Tumors Immune System Autoimmune Disease Autoimmunity Rheumatoid Arthritis Hematologic Malignancies Atopic Dermatitis Dermatitis Hidradenitis Suppurativa
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 45.31 |
52 Week Low | 9.6 |
Average Volume | 590,700 |
200-Day Moving Average | 26.75 |
50-Day Moving Average | 37.44 |
20-Day Moving Average | 36.10 |
10-Day Moving Average | 37.17 |
Average True Range | 1.84 |
RSI (14) | 43.50 |
ADX | 21.87 |
+DI | 16.78 |
-DI | 24.60 |
Chandelier Exit (Long, 3 ATRs) | 34.12 |
Chandelier Exit (Short, 3 ATRs) | 38.26 |
Upper Bollinger Bands | 39.63 |
Lower Bollinger Band | 32.56 |
Percent B (%b) | 0.34 |
BandWidth | 19.56 |
MACD Line | -0.13 |
MACD Signal Line | -0.03 |
MACD Histogram | -0.0963 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 36.71 | ||||
Resistance 3 (R3) | 36.76 | 36.22 | 36.41 | ||
Resistance 2 (R2) | 36.22 | 35.78 | 36.20 | 36.31 | |
Resistance 1 (R1) | 35.59 | 35.50 | 35.32 | 35.54 | 36.22 |
Pivot Point | 35.05 | 35.05 | 34.92 | 35.03 | 35.05 |
Support 1 (S1) | 34.42 | 34.61 | 34.15 | 34.37 | 33.68 |
Support 2 (S2) | 33.88 | 34.33 | 33.86 | 33.59 | |
Support 3 (S3) | 33.25 | 33.88 | 33.49 | ||
Support 4 (S4) | 33.20 |